At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 10 enrolled
Drug / intervention
lycopene +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Placebo Controlled Trial of Preoperative Lycopene Supplementation in Prostate Cancer Patients
In Brief
A Phase 2 clinical trial evaluating placebo, therapeutic conventional surgery, and 2 other interventions for Adenocarcinoma of the Prostate and 3 related conditions. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2007
Enrollment StartFeb 2008
Primary CompletionMay 2010
TodayJul 2026
First PostedMar 22, 2007
Enrollment StartFeb 1, 2008
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 19.3 years ago
Interventions
placeboother
Given PO
therapeutic conventional surgeryprocedure
Undergo radical prostatectomy
laboratory biomarker analysisother
Correlative studies
lycopenedrug
Given PO